Company Profile Offices Service Offered ISO certification quality policy knowledge center 20th anniversary 25th anniversary
Portfolio Management Depository Services NRI Cell Internet Trading Knowledge Center Gold etf Currency Trading CLIENT IPV(RM LOGIN)
Equity Derivatives IPO Insurance Currency
Morning Capstocks Conviction Ideas Monthly Recommendations Current Market Scenario IPO/NFO Synopsis Technical Ideas
Downloads Digital Contract Notes Online Trading Demo News & Events

Market & News

graph-market Equity

ProgressImage ProgressImage
Alivus Life Sciences Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code 543322 border-img ISIN Demat INE03Q201024 border-img Book Value 229.75 border-img NSE Symbol ALIVUS border-img Div & Yield % 0.45 border-img Market Cap (₹ Cr.) 13496.56 border-img P/E 27.79 border-img EPS 39.6 border-img Face Value 2
Date Headline
16-05-2025 Board of Alivus Life Sciences recommends final dividend
16-05-2025 Alivus Life Sciences standalone net profit rises 44.85% in the March 2025 quarter
16-05-2025 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Dividend
16-05-2025 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
09-05-2025 Alivus Life Sciences to hold board meeting
09-05-2025 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Board Meeting
02-05-2025 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Other General Purpose
30-04-2025 Alivus Life Sciences allots 92,096 equity shares under ESOS
03-04-2025 Alivus Life Sciences Ltd - Glenmark Life Sciences Limited - Acquisition
02-04-2025 Alivus Life Sciences Ltd - Alivus Life Sciences Limited - Acquisition
x
capstocks-logo
 
Date & Time -()
 

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

MEMBERS IN : NSE, BSE, MCX – DP : CDSL – Portfolio ManagerHelpdesk: helpdesk@capstocks.com

SEBI registered broker Nos: NSE, BSE & MCX: INZ000165931 | DP: IN-DP-CDSL-203-2003 | PMS: INP000001066 | Research Entity SEBI Reg No: INH200003109, |
BSE Enlisted No: 5189 | Member ID : NSE: 11674, BSE : 3086, MCX : 55990

Investor Grievances : Customer.redressal@capstocksindia.com

GST Numbers

CIN No U67120KL2001PTC014680

© 2018 Capstocks and Securities(India) Pvt. LTD All rights reserved.

Designed, Developed and content powered by CMOTS Infotech( ISO 9001:2015 certified )

x
capstocks-logo
GST
 
x
Investment
 
×
Let's Chat
close
refresh